Sorafenib analogues exhibit dual Colistin-potentiating and anti-MRSA activity
- DOI
- 10.1039/d6md00388e
- Published
- 2026
- Container
- RSC Medicinal Chemistry
- Publisher
- Royal Society of Chemistry (RSC)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1039/d6md00388e,
title = {Sorafenib analogues exhibit dual Colistin-potentiating and anti-MRSA activity},
author = {Amy Sorge and Andrew Stiles and Ansley M. Nemeth and Ian O'Keefe and Roberta J. Melander and Yohei Doi and Robert K. Ernst and Christian Melander},
year = {2026},
journal = {RSC Medicinal Chemistry},
doi = {10.1039/d6md00388e},
url = {https://doi.org/10.1039/d6md00388e}
}RIS
TY - JOUR TI - Sorafenib analogues exhibit dual Colistin-potentiating and anti-MRSA activity AU - Amy Sorge AU - Andrew Stiles AU - Ansley M. Nemeth AU - Ian O'Keefe AU - Roberta J. Melander AU - Yohei Doi AU - Robert K. Ernst AU - Christian Melander PY - 2026 JO - RSC Medicinal Chemistry DO - 10.1039/d6md00388e UR - https://doi.org/10.1039/d6md00388e ER -
APA
Sorge, A., Stiles, A., Nemeth, A. M., O'Keefe, I., Melander, R. J., Doi, Y., Ernst, R. K., & Melander, C. (2026). Sorafenib analogues exhibit dual Colistin-potentiating and anti-MRSA activity. RSC Medicinal Chemistry. https://doi.org/10.1039/d6md00388e
Source records
- crossref · retrieved 2026-09-27T00:39:12.172Z